BioXcel Therapeutics, Inc.

BTAI · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Operating Activities
Net Income-$31-$19-$7-$11
Dep. & Amort.$0$0$0$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$2$0$0
Change in WC-$2$2-$2-$4
Other Non-Cash$14$3-$3-$0
Operating Cash Flow-$19-$13-$12-$15
Investing Activities
PP&E Inv.$0$0$0$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow$0$0$0$0
Financing Activities
Debt Repay.$0$0$0-$3
Stock Issued$38$0$14$7
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.-$0-$0-$1-$0
Financing Cash Flow$38$0$13$4
Forex Effect$0$0$0$0
Net Chg. in Cash$19-$12$1-$11
Supplemental Information
Beg. Cash$19$31$30$40
End Cash$37$19$31$30
Free Cash Flow-$19-$13-$12-$15